Fremanezumab Boosts Sleep Quality in Chronic Migraine Sufferers

Research Summary

A study published in Clinical Neurology and Neurosurgery explored the impact of fremanezumab on sleep quality in chronic migraine patients over six months. Involving 82 patients and 80 healthy controls, the research employed the Pittsburgh Sleep Quality Index (PSQI) alongside anxiety and depression assessments. Initially, chronic migraine patients had significantly higher PSQI scores than controls (p<0.01). Notably, fremanezumab therapy improved PSQI global scores and some subscores over time (p<0.01). Higher sleep disturbance correlated with increased headache impact, anxiety, depression, and factors like gender, age, and BMI. The study highlights fremanezumab's positive effect on sleep quality in chronic migraine sufferers.

Study Details

📄 Title: Quality of sleep in chronic migraine patients treated with fremanezumab - 6 months follow-up.

👥 Research Team: Stojanov A, Stojanov J, Djordjevic G

📚 Published In: Clin Neurol Neurosurg

📅 Publication Date: 2025 Nov 24

⚕️ Medical Disclaimer: This summary is generated automatically from recent migraine research. Always consult with healthcare professionals for medical advice.